Millennium Research Group has conducted a detailed analysis of the therapeutic botulinum toxin market in its Global Markets for Therapeutic Botulinum Toxin 2007 report. The analysis reveals that an increasing number of patients will receive BTX treatment for therapeutic use over the next five years in the US as there is an expanding range of indications which will drive the market to over $850 …
More: continued here